Viewing nowCombinationDuoWell Plus Tablet 40/20/10 Milligrams
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 202106633 · Approved 2021.09.24 · Insurance code 642105830
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medication is used for patients who need to take Telmisartan and Rosuvastatin/Ezetimibe simultaneously. Telmisartan helps in treating essential hypertension and is effective in reducing the risk of cardiovascular diseases. Particularly, it lowers the risk of myocardial infarction, stroke, and cardiovascular-related mortality in high-risk patients aged over 55 who cannot use ACE inhibitors. Rosuvastatin/Ezetimibe regulates cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, reducing total cholesterol and LDL cholesterol while increasing HDL cholesterol, contributing to the improvement of blood lipid levels. This medication is used to simultaneously manage hypertension and dyslipidemia to enhance cardiovascular health.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of telmisartan is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg once daily. Patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborns during pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. Severe muscle problems may occur; if symptoms such as muscle pain or weakness appear, consult a doctor immediately. Patients with poor liver function or a history of liver disease should consult with a physician before taking this medication and undergo liver function tests regularly. Patients with severely impaired kidney function or certain kidney diseases should avoid taking this medication. If there are specific allergies or genetic metabolic disorders, this medication should not be taken, and caution is required for patients sensitive to the ingredients. Interactions may occur with other medications; therefore, if currently taking other medications, inform the doctor or pharmacist. During the use of this medication, regular blood tests, liver function tests, and kidney function tests should be performed, and if any abnormal symptoms appear, inform the medical staff immediately. Patients who excessively consume alcohol or have a history of liver disease should exercise caution when taking this medication. Caution is advised during driving or operating machinery as dizziness or drowsiness may occur. Patients with other chronic diseases such as hypertension or diabetes should have thorough assessments and evaluations before taking this medication. Due to the risk of muscle damage, if muscle pain worsens after intense exercise, discontinue use and consult a doctor. Particularly in elderly patients or those with specific genetic predispositions, the risk of muscle-related side effects is higher, requiring caution. It is important to maintain adequate hydration and nutritional management during the use of this medication. During the course of treatment, symptoms such as gastrointestinal disturbances, rash, headache, dizziness, and fatigue may occur; consult a medical professional if these symptoms arise.
Increased ALT, Increased AST, Increased Ɣ-GTP, Increased ALP, Abdominal pain, Oral ulcers, Vomiting, Chest pain, Palpitations, Dizziness, Shortness of breath, Functional abnormalities of the Eustachian tube, Tympanic membrane perforation, Acute kidney injury, Hematuria, Herpes zoster, Pneumonia, Non-small cell lung cancer, Hair loss, Dysuria, Rhinitis, Discomfort in the oropharynx, Lung disease, Unspecified gastrointestinal disease, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory loss, Movement disorders, Atherosclerosis, Frequent urination, Tinnitus, Hearing loss, Halitosis, Fatty liver, Chest tightness, Facial swelling, Strange sensations, Drug intolerance, Colonic polyps, Irritable bowel syndrome, Esophagitis, Drowsiness, Neurodegenerative disorders, Orthostatic dizziness, Migraine, Diabetes mellitus, Impaired glucose tolerance, Depression, Bronchitis, Rhinitis, Cystitis, Onychomycosis, Soft tissue infection, Liver steatosis, Liver dysfunction, Hepatotoxicity, Acute hepatitis, Toxic hepatitis, Increased gamma-glutamyl transferase, Increased blood cholesterol, Increased alkaline phosphatase, Irregular heart rate, Osteoarthritis, Musculoskeletal stiffness, Musculoskeletal discomfort, Muscle weakness, Sweating, Dermatitis, Skin burning sensation, Skin disorders, Alopecia, Oropharyngeal pain, Nasal congestion, Breathing difficulties, Pelvic pain, Breast cysts, Eyelid droop, Diabetic retinopathy, Ear discomfort, Renal dysfunction, Benign esophageal neoplasm, Headache, Facial spasms, Sensory abnormalities, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Loss of appetite, Edema, Decreased libido, Facial edema, Rash, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Abdominal pain, Diarrhea, Dyspepsia, Abdominal distension, Abdominal discomfort, Dry mouth, Liver function abnormalities, Liver dysfunction, Increased sweating, Itching, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Low back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Asthenia, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated serum creatine kinase, Decreased hemoglobin, Shock, Loss of consciousness, Jaundice, Anaphylactic-like symptoms, Interstitial pneumonia, Rhabdomyolysis, Fatigue, Nausea, Inadequate effect, Joint pain, Numbness, Chest discomfort, Loss of appetite, Abdominal distension, Abnormal liver function tests, Generalized pain, Muscle cramps, Gout, Urticaria, Hyperhidrosis, Dermatitis, Itching, Upper respiratory infection, Conjunctival congestion, Renal failure, Abnormal liver function tests, Polyneuropathy, Amnesia, Peripheral neuropathy, Diarrhea, Stevens-Johnson syndrome, Eosinophilia and systemic symptom-associated drug reaction syndrome, Lupus-like syndrome, Muscle rupture, Immune-mediated necrotizing myopathy, Hematuria, Edema, Headache, Cough, Weakness, Facial spasms, Sensory abnormalities, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Loss of appetite, Edema, Decreased libido, Facial edema, Rash, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Abdominal pain, Diarrhea, Dyspepsia, Abdominal distension, Abdominal discomfort, Dry mouth, Liver function abnormalities, Liver dysfunction, Increased sweating, Itching, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Low back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Asthenia, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated serum creatine kinase, Decreased hemoglobin, Shock, Loss of consciousness, Jaundice, Anaphylactic-like symptoms, Interstitial pneumonia, Rhabdomyolysis, Fatigue, Nausea, Inadequate effect, Joint pain, Numbness, Chest discomfort, Loss of appetite, Abdominal distension, Abnormal liver function tests, Generalized pain, Muscle cramps, Gout
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This will ensure the medication's efficacy is safely maintained over time.
Yellow oval film-coated tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
(Co., Ltd.) Green Cross
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.